More Direct-To-Patient Programs Unveiled With MFN Pricing Deadline Looming

 
• By Alaric DeArment and Sarah Karlin-Smith
  
The Trump Administration's deadline to commit to MFN pricing is Sept. 29. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from United States